PLG and Alzheimer disease: Interestingly, a recent study has shown that administration of a PAI‐1 inhibitor for a period of 6 weeks reduces Aβ load in the hippocampus and cortex and improve learning and memory function in an AD mouse model.116 Notably, these effects were associated with increased tPA and plasmin activities.